BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 36379354)

  • 21. Computational modeling of the metabolic States regulated by the kinase akt.
    Mosca E; Alfieri R; Maj C; Bevilacqua A; Canti G; Milanesi L
    Front Physiol; 2012; 3():418. PubMed ID: 23181020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycolysis in Innate Immune Cells Contributes to Autoimmunity.
    Xu Y; Chen Y; Zhang X; Ma J; Liu Y; Cui L; Wang F
    Front Immunol; 2022; 13():920029. PubMed ID: 35844594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting glycolysis in proliferative kidney diseases.
    Ghazi S; Polesel M; Hall AM
    Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1531-F1535. PubMed ID: 31709806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. pH dependencies of glycolytic enzymes of yeast under in vivo-like assay conditions.
    Luzia L; Lao-Martil D; Savakis P; van Heerden J; van Riel N; Teusink B
    FEBS J; 2022 Oct; 289(19):6021-6037. PubMed ID: 35429225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycolysis is the primary bioenergetic pathway for cell motility and cytoskeletal remodeling in human prostate and breast cancer cells.
    Shiraishi T; Verdone JE; Huang J; Kahlert UD; Hernandez JR; Torga G; Zarif JC; Epstein T; Gatenby R; McCartney A; Elisseeff JH; Mooney SM; An SS; Pienta KJ
    Oncotarget; 2015 Jan; 6(1):130-43. PubMed ID: 25426557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic Pathways of the Warburg Effect in Health and Disease: Perspectives of Choice, Chain or Chance.
    Burns JS; Manda G
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29257069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From steady-state to synchronized yeast glycolytic oscillations II: model validation.
    du Preez FB; van Niekerk DD; Snoep JL
    FEBS J; 2012 Aug; 279(16):2823-36. PubMed ID: 22686585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mini-review on glycolysis and cancer.
    Akram M
    J Cancer Educ; 2013 Sep; 28(3):454-7. PubMed ID: 23728993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor glycolysis as a target for cancer therapy: progress and prospects.
    Ganapathy-Kanniappan S; Geschwind JF
    Mol Cancer; 2013 Dec; 12():152. PubMed ID: 24298908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma.
    Chen DP; Ning WR; Jiang ZZ; Peng ZP; Zhu LY; Zhuang SM; Kuang DM; Zheng L; Wu Y
    J Hepatol; 2019 Aug; 71(2):333-343. PubMed ID: 31071366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Harnessing bioactive nanomaterials in modulating tumor glycolysis-associated metabolism.
    Gu Z; Yu C
    J Nanobiotechnology; 2022 Dec; 20(1):528. PubMed ID: 36510194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Key Glycolytic Enzyme Phosphofructokinase Is Involved in Resistance to Antiplasmodial Glycosides.
    Fisher GM; Cobbold SA; Jezewski A; Carpenter EF; Arnold M; Cowell AN; Tjhin ET; Saliba KJ; Skinner-Adams TS; Lee MCS; Odom John A; Winzeler EA; McConville MJ; Poulsen SA; Andrews KT
    mBio; 2020 Dec; 11(6):. PubMed ID: 33293381
    [No Abstract]   [Full Text] [Related]  

  • 34. Glycolysis inhibition for anticancer treatment.
    Pelicano H; Martin DS; Xu RH; Huang P
    Oncogene; 2006 Aug; 25(34):4633-46. PubMed ID: 16892078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Examining
    Hollinshead WD; Rodriguez S; Martin HG; Wang G; Baidoo EE; Sale KL; Keasling JD; Mukhopadhyay A; Tang YJ
    Biotechnol Biofuels; 2016; 9():212. PubMed ID: 27766116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycolysis-citric acid cycle interrelation: a new approach and some insights in cellular and subcellular compartmentation.
    Lai JC; Behar KL
    Dev Neurosci; 1993; 15(3-5):181-93. PubMed ID: 7805570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microevolution of intermediary metabolism: evolutionary genetics meets metabolic biochemistry.
    Zera AJ
    J Exp Biol; 2011 Jan; 214(Pt 2):179-90. PubMed ID: 21177939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology.
    Kierans SJ; Taylor CT
    J Physiol; 2021 Jan; 599(1):23-37. PubMed ID: 33006160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integration of flux measurements to resolve changes in anabolic and catabolic metabolism in cardiac myocytes.
    Gibb AA; Lorkiewicz PK; Zheng YT; Zhang X; Bhatnagar A; Jones SP; Hill BG
    Biochem J; 2017 Aug; 474(16):2785-2801. PubMed ID: 28706006
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.